Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open. 2020;6(3).

28/02/2022

Michelsen B, Lindström U, Codreanu C, Ciurea A, Zavada J, Loft AG, et al.

Epub 2020/09/21. doi: 10.1136/rmdopen-2020-001280. PubMed PMID: 32950963.